SETD3 and renal cell carcinoma: SETD3 was identified as novel biomarker for renal cell carcinoma (RCC)3: SETD3 expression was significantly higher in a set of RCC samples compared to normal renal tissues, and high expression of SETD3 was inversely correlated with disease-free survival3.